Menu
Share this

News

PPD Appoints Experienced Industry Leader to Guide PPD® Laboratories

PPD announced it has appointed Christopher C. Fikry, M.D., as executive vice president of PPD® Laboratories.

27 Jun. 2017

PPD Clinical Research Associates Recognized for Excellence

PPD announced industry accolades earned by PPD clinical research associates (CRAs), recognizing their expertise in the endeavor of developing life-changing medicines.

08 Jun. 2017

PPD Recognized for Leadership in Clinical Research

PPD announced it has been recognized for excellence in clinical research by pharmaceutical and biotechnology executives surveyed for Life Science Leader magazine’s 2017 CRO Leadership Awards.

25 May 2017

Acurian Announces Hiring of Tom Privette to Lead Global Business Development

Acurian Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, announced that Tom Privette, Ph.D., has joined the company as vice president and head of global business development.

23 May 2017

PPD Expands Vaccine Development Laboratory

PPD has expanded its vaccine sciences lab in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ growing research needs.

18 May 2017

Acurian Introduces Consulting Services for Advance Clinical Trial Enrollment Planning

Acurian Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, has launched a new consulting offering to aid pharmaceutical sponsors in advance strategic planning for clinical trials enrollment.

17 May 2017

PPD Strengthens Expertise in Neuroscience, Pediatrics and Rare Diseases

PPD announced it recently has added two new leaders in product development, strengthening the global contract research organization’s therapeutic expertise and ability to aid biopharmaceutical clients in delivering life-changing therapies to patients.

11 May 2017

PPD Creates Dedicated Real-world Research and Market Access Unit by Combining Medical Affairs Research Operations and Evidera

PPD announced the creation of a dedicated unit combining its medical affairs research operations (MARO) team and Evidera, the provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of biopharmaceutical and biotechnology products.

08 May 2017

PPD to Recapitalize with Existing Owners and Investors

PPD announced that its existing owners, affiliates of Hellman & Friedman and affiliates of The Carlyle Group, have entered into definitive agreements to recapitalize PPD and expand the company’s ownership to include two new investors, a subsidiary of the Abu Dhabi Investment Authority and an affiliate of GIC, Singapore’s sovereign wealth fund.

26 Apr. 2017

PPD Heroes Advocate for Clinical Research to Improve Patient Health

PPD announced the kickoff of its 2017 educational campaign to raise awareness about the life-changing impact of clinical research, featuring a team of PPD Heroeswho share their personal stories to inspire hope.

20 Apr. 2017

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
PPD
Tel: +1 919 456 4425

Elizabeth Humphrey Corporate Communications Manager
PPD
Tel: +1 910 558 6096

Contact Site Map Legal Notices Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.

Google+